Short interest for Reckitt Benckiser Group gives investors a sense of the degree to which investors are betting on the decline of Reckitt Benckiser Group's stock. Short interest data is updated every two weeks.

Reckitt Benckiser Group Stock (OTC:RBGLY), Short Interest Report

Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.

Port,Charlotte,,Florida,-,February,15,,2022:,Yellow,Enfamil,Formula

Large Cap

News

Health Care

Legal

Movers

General

RBGLY

RBGPF

An Illinois jury orders Reckitt Benckiser&#39;s Mead Johnson to pay $60 million after a premature infant&#39;s tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about NEC risks. Over 400 NEC lawsuits pending in federal court in Chicago.

What&#39;s Going On With Abbott Laboratories Stock On Friday?

Android Phone

Social Media

Global

Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight.

Durex Owner Reckitt Benckiser Taps Into China&#39;s Livestreaming Trend To Sell Condoms Online

Can,Of,Powdered,Infant,Formula,With,Scoop,On,Table,,Closeup.

A massive recall of hypoallergenic infant formula has been initiated due to concerns over potential bacteria contamination. The recall involves approximately 675,000 cans of infant formula.

Reckitt&#39;s Mead Johnson Initiates Massive Recall Of 675K Cans Of Hypoallergenic Baby Formula Over Bacteria Contamination Fears

RECKITT BENCKISR GP S/ADR by Reckitt Benckiser Group Plc.

Reckitt Benckiser Group PLC

Guidance

NTGR

Netgear Sees Q2 2024 Net Revenue $125M-$140M

Adjusted EBITDA&nbsp;in the range of&nbsp;$720 million&nbsp;to&nbsp;$730 million.

PAYC

Paycom Software Continues To See FY24 Total Revenues Of $1.86B-$1.885B, Est $1.872B

Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.64) by 3.13 percent. This is a 82.35 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $200.700 million which missed the analyst consensus estimate of $201.110 million by 0.20 percent. This is a 4.21 percent increase over sales of $192.600 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

WOLF

Wolfspeed Q3 2024 Adj EPS $(0.62) Beats $(0.64) Estimate, Sales $200.700M Miss $201.110M Estimate

Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) reported quarterly earnings of $2.22 per share which met the analyst consensus estimate. This is a 2.63 percent decrease over earnings of $2.28 per share from the same period last year. The company reported quarterly sales of $543.62 million which beat the analyst consensus estimate of $542.72 million by 0.17 percent. This is a 2.76 percent increase over sales of $529.03 million the same period last year.

Mid-America Apartment Q1 FFO $2.22, Inline, Sales $543.62M Beat $542.72M Estimate

TTEK

Tetra Tech Sees FY24 EPS ~$6.25 Vs $6.87 Estimate, Sees Revenue ~$4.31B Vs $4.59B Estimate

Second Quarter and Full Year 2024 Guidance
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Q2 2024</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Full Year 2024</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Revenue (millions)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$130.0 - $134.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$555.0 - $565.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP Operating Loss (millions)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($16.0) - ($12.0)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($28.0) - ($22.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP Net Loss per share (4)(5)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($0.10) - ($0.06)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($0.12) - ($0.06)</td>
</tr>
</tbody>
</table>
</figure>
A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future and cannot be reasonably determined or predicted at this time, although it is important to note that these factors could be material to Fastly's future GAAP financial results.

FSLY

Fastly Sees Q2 EPS $(0.10)-$(0.06) Vs $(0.02) Est.; Revenue $130M-$134M Vs $140.16M Est.; FY24 EPS $(0.12)-$(0.06) Vs $(0.03) Est.; Revenue $555M-$565M Vs $584.59M Est.

NOVA

Sunnova Energy Sees FY24 Customer Additions 140,000-150,000; Adj. EBITDA $350M-$450M

Adjusted EBITDA&nbsp;in the range of&nbsp;$151 million&nbsp;to&nbsp;$155 million. 
&nbsp;

Paycom Software Expects Q2 Total Revenues Of $434M-$438M, Est $442.133M

AtriCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 8.7 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $108.851 million which beat the analyst consensus estimate of $106.902 million by 1.82 percent. This is a 16.43 percent increase over sales of $93.494 million the same period last year.

ATRC

AtriCure Q1 2024 Adj EPS $(0.25) Misses $(0.23) Estimate, Sales $108.851M Beat $106.902M Estimate

The following is a summary of the Company's full-year 2024 guidance:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">For the Year Ending December 31, 2024 ($ in millions):</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Low</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated Adjusted Funds From Operations (AFFO)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2,320</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2,355</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated Adjusted Funds From Operations (AFFO) per diluted share</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2.22</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2.25</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated Weighted Average Share Count for the Year (in millions)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">1,046.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">1,046.0</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

VICI

VICI Properties Reaffirms Guidance

PC Connection (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXN#NASDAQ">CNXN</a>) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.64 by 21.88 percent. The company reported quarterly sales of $632.000 million which missed the analyst consensus estimate of $694.187 million by 8.96 percent. This is a 13.13 percent decrease over sales of $727.545 million the same period last year.

CNXN

PC Connection Q1 2024 GAAP EPS $0.50 Misses $0.64 Estimate, Sales $632.000M Miss $694.187M Estimate

VICI Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>) reported quarterly earnings of $0.56 per share which met the analyst consensus estimate. The company reported quarterly sales of $951.50 million which beat the analyst consensus estimate of $936.67 million by 1.58 percent. This is a 8.41 percent increase over sales of $877.65 million the same period last year.

VICI Props Q1 2024 GAAP EPS $0.56, Inline, Sales $951.50M Beat $936.67M Estimate

Benchmark Electronics Sees Q2 Adj. EPS $0.48-$0.54 vs $0.41 Est., Revenue $615M-$655M vs $632.9M Est.

Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.32 by 18.75 percent. This is a 31.58 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $623.600 million which missed the analyst consensus estimate of $634.108 million by 1.66 percent. This is a 0.57 percent decrease over sales of $627.200 million the same period last year.

NVST

Envista Holdings Q1 2024 Adj EPS $0.26 Misses $0.32 Estimate, Sales $623.600M Miss $634.108M Estimate

WIIM

BFLY

Butterfly Network shares are trading higher after the company reported better-than-expected Q1 financial results.

GKOS

Glaukos Sees FY24 Net Sales $357M-$365M Vs $356.669M Est.

CORT

Corcept Therapeutics Increases FY24 Revenue Guidance From $600M-$630M To $620M–$650M Vs $610.64M Est

Woodside, currently Freshworks&#39; President, will succeed Girish Mathrubootham, the company&#39;s Founder, as CEO.

Management

FRSH

Freshworks Appoints Dennis Woodside As CEO & President, Effective Later Today; Girish Mathrubootham Will Transition To A New Role Of Executive Chairman

Evertec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTC#NYSE">EVTC</a>) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.68 by 5.88 percent. The company reported quarterly sales of $205.30 million which beat the analyst consensus estimate of $202.24 million by 1.51 percent. This is a 28.46 percent increase over sales of $159.81 million the same period last year.

EVTC

Evertec Q1 2024 Adj EPS $0.72 Beats $0.68 Estimate, Sales $205.30M Beat $202.24M Estimate

ENVX

Enovix shares are trading higher after the company reported mixed Q1 financial results.

International Wide-Moat Stocks On Sale - The March 2024 Heat Map

Walgreens settles with New York over price gauging on baby formula

Abbott falls after setback to Reckitt Benckiser in baby formula case

These Consumer Defensive stocks are trading higher:-Laird Superfood Inc (LSF) stock is trading at $2.91, an increase of $0.52, or 21.76%, on high volume.  Laird Superfood Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $1.68.  -Ispire

Consumer Defensive Stocks Moving Friday: LSF, ISPR, AFYA, GROV, RBGLY, HPCO, DAO, ZVIA

These Consumer Defensive stocks are trading higher:-Eastside Distilling Inc (EAST) stock is trading at $1.46, a gain of $0.15, or 11.45%, on low volume.  Eastside Distilling Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.00

Consumer Defensive Stocks Moving Tuesday: EAST, SKIN, LINC, CLEU, BYND, LSF, QSG, RBGLY

Warning: RBGLY is at high risk of performing badly

Oakmark Global Select Fund: First Calendar Quarter 2024

International Wide-Moat Stocks On Sale - The April 2024 Heat Map

Reckitt Benckiser Group plc (RBGPF) Q1 2024 Earnings Call Transcript

Artisan Global Value Fund Q1 2024 Commentary

ABEV

AFYA

ALLE

ASXFF

ASXFY

AZNCF

BABA

BABAF

BAIDF

BIDU

BRRLY

BTAFF

BUDFF

BYCBF

BYND

CBRE

CFRHF

CFRUY

CHTR

CLEU

DGEAF

EAST

EDNMF

EDNMY

FANUF

FANUY

GEAGF

GLAXF

GROV

HDELY

HKXCF

HKXCY

HLBZF

HPCO

HSIC

HSYDF

IMBBF

IMBBY

ISPR

JDCMF

KAOCF

KAOOY

KNYJF

KNYJY

LINC

NCTKF

NCTKY

NSRGF

NSRGY

OMRNF

OMRNY

PDRDF

PRNDY

RHHBF

RHHBY

RHHVF

SKIN

SNYNF

SPXCF

SPXCY

SPXSF

SPXSY

TCEHY

TCTZF

TDBCP

TDBKF

TNTTF

UNLYF

XRAY

YUMC

ZVIA

Press Releases

Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt Benckiser Group PLC Following $60 Million Baby Formula Verdict and Subsequent Stock Plummet

Reckitt Benckiser Group

Bernstein